Additionally, if patients experience GBS-related adverse reactions while taking medications potentially associated with TNF-α in Figure 6A, the possibility of persistently activated myelin-specific T cells due to excessively low TNF-α levels should be considered. Here, TNF is linked to Guillain-Barre syndrome.